Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. annual/quarterly long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Pacira BioSciences Inc. long term debt for the quarter ending December 31, 2025 were 372.2M, a 36.41% decrease year-over-year.
- Pacira BioSciences Inc. long term debt for 2025 were 372.2M, a 36.41% decrease from 2024.
- Pacira BioSciences Inc. long term debt for 2024 were 585.3M, a 12.04% increase from 2023.
- Pacira BioSciences Inc. long term debt for 2023 were 522.4M, a 24.23% decrease from 2022.
- Pacira BioSciences Inc. long term debt for 2022 were 689.5M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Pacira BioSciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $372 |
| 2024 | $585 |
| 2023 | $522 |
| 2022 | $689 |
| 2016 | $109 |
| 2015 | $104 |
| 2014 | $103 |
| 2013 | $99 |
| 2012 | $25 |
| 2011 | $26 |
| 2010 | $22 |
| Pacira BioSciences Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $372 |
| 2024-12-31 | $585 |
| 2023-12-31 | $522 |
| 2022-12-31 | $689 |
| 2016-12-31 | $109 |
| 2015-12-31 | $104 |
| 2014-12-31 | $103 |
| 2013-12-31 | $99 |
| 2012-12-31 | $25 |
| 2011-12-31 | $26 |
| 2010-12-31 | $22 |
Pacira BioSciences Inc. Long Term Debt — FAQ
Pacira BioSciences Inc. (PCRX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's long term debt history?
The chart and table above show Pacira BioSciences Inc.'s long term debt by year and by quarter, including the growth rate.